Abstract
Objective: to evaluate the clinical characteristics of patients with GDM depending on the treatment received to conïŹrm the presence of various subtypes of GDM.Materials and methods: a retrospective analysis of the medical records of 474 pregnant women with GDM was carried out. The subjects were divided depending on the treatment method received: I group â 353 pregnant women with GDM who received only diet therapy, II group â 121 pregnant women with GDM who used both diet and insulin therapy. Biochemical and general blood tests, coagulograms at the 20th and 30th weeks of pregnancy, ultrasound results, pharmacological history, concomitant complications and pregnancy outcomes were analyzed. The statistical analysis of the results of the study was carried out using R. The diïŹerences were recognized as statistically signiïŹcant at the level of p < 0.05.Results: age, blood pressure, weight and BMI in each trimester and before childbirth did not diïŹer statistically signiïŹcantly among the groups. Patients receiving insulin therapy had higher levels of urea (p = 0.009), AST (p = 0.03), ALT (p = 0.02), prothrombin (p = 0.02) and D-dimer (p = 0.047). According to the ultrasound data, no signiïŹcant diïŹerences were found. An assessment of the pharmacological history revealed a more frequent use of progesterone preparations in patients with insulin therapy. Concomitant diseases were comparable in patients from diïŹerent groups.Conclusion: despite the absence of signiïŹcant diïŹerences among the observation groups, the results obtained do not exclude the presence of diïŹerent subtypes of GSD, but suggest that there is an unjustiïŹed prescription of insulin therapy in cases where more intensive dietary changes are required. Of course, further study of this problem is required to conïŹrm the presence of various subtypes of GDM.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have